electroCore Stock (NASDAQ:ECOR)
Previous Close
$9.93
52W Range
$4.16 - $10.40
50D Avg
$7.24
200D Avg
$6.00
Market Cap
$84.45M
Avg Vol (3M)
$101.58K
Beta
0.87
Div Yield
-
ECOR Company Profile
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
ECOR Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Countries | $22.00K | - | - | - | - | - | - | - | - | - | - | - |
| JAPAN | $18.00K | $46.00K | $46.00K | $45.00K | $48.00K | - | - | - | - | - | - | - |
| UNITED STATES | $3.13M | $2.37M | $2.13M | $1.56M | $1.69M | $1.59M | $1.13M | $1.10M | - | - | - | - |
| Other | - | $43.00K | $55.00K | $25.00K | $64.00K | $39.00K | $26.02K | $16.52K | $32.94K | $62.88K | $8.98K | $1.73K |
| Americas | - | - | - | - | - | - | - | - | $882.57K | $823.98K | $800.77K | - |
| Europe | - | - | - | - | - | - | - | - | - | $316.99K | $278.34K | - |
Fiscal year ends in Dec 25 | Currency in USD